One-visit, randomized, placebo-controlled, conjunctival allergen challenge study of scanning and imaging technology for objective quantification of eyelid swelling in the allergic reaction with contralateral use of olopatadine and artificial tears

Clinical Therapeutics

Volumn 25, Issue 7, 2003, Pages 2070-2084

  Abelson, Mark B ^a,b,f   Pratt, Steven ^c   Mussoline, Joseph F ^d   Townsend, Daniel ^a,e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^c SCRIPPS MEMORIAL HOSPITAL   (United States)

^d WILLS EYE HOSPITAL   (United States)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NONE   (United States)

Author keywords

Conjunctival allergen challenge model; Eyelid swelling; Olopatadine hydrochloride 0.1

Indexed keywords

ACETYLSALICYLIC ACID; ALLERGEN; ANTIHISTAMINIC AGENT; ARTIFICIAL TEAR; BOTULINUM TOXIN; CORTICOSTEROID; EYE DROPS; OLOPATADINE; PLACEBO;

ADULT; AGED; ALLERGIC REACTION; ARTICLE; CALCULATION; CHEMOSIS; CLINICAL TRIAL; CONJUNCTIVA; CONSULTATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFICACY; DRUG FORMULATION; DRUG INSTILLATION; DRUG MECHANISM; EYELID EDEMA; FEMALE; HUMAN; MALE; MEDICAL ASSESSMENT; PROSPECTIVE STUDY; PROVOCATION TEST; PRURITUS; RANDOMIZED CONTROLLED TRIAL; THREE DIMENSIONAL IMAGING;

EID: 0042703264     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(03)80205-9     Document Type: Article

References (30)

1. Juniper EF, Guyatt GH, Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: Development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol. 1994;93:413-423.
2. American Society for Aesthetic Plastic Surgery (ASAPS). News release: March 4, 2003. Available at: http://www.surgery.org/news_releases/mar0303stats.html.
3. Beltrani VS. Eyelid dermatitis. Curr Allergy Asthma Rep. 2001;1:380-388.
4. Langley KE, Patrinely JR, Anderson RL, Thiese SM. Unilateral blepharochalasis. Ophthalmic Surg. 1987;18:594-598.
5. Bergin DJ, McCord CD, Berger T, et al. Blepharochalasis. Br J Ophthalmol. 1988;72:863-867.
6. Collin JR. Blepharochalasis. A review of 30 cases. Ophthal Plast Reconstr Surg. 1991;7:153-157.
7. Finney JL, Peterson HD. Blepharochalasis after a bee sting. Plast Reconstr Surg. 1984;73:830-832.
8. Trenam CW, Dabbagh AJ, Morris CJ, Blake DR. Skin inflammation induced by reactive oxygen species (ROS): An in-vivo model. Br J Dermatol. 1991;125:325-329.
9. Lavker RM, Kligman AM. Chronic heliodermatitis: A morphologic evaluation of chronic actinic dermal damage with emphasis on the role of mast cells. J Invest Dermatol. 1988;90:325-330
10. Chen DM, Crosby DL. Periorbital edema as an initial presentation of rosacea. J Am Acad Dermatol. 1997;37:346-348
11. Smith NH, Rados WT, Cohen FB, Cinotti AA. Malignant lymphoma presenting as bilateral swelling of the eyelid. J Med Soc N J. 1977;74:968-970.
12. Jacobson DM. Dysthyroid orbitopathy. Semin Neurol. 2000;20:43-54.
13. Dupouy-Camet J, Kociecka W, Bruschi F, et al. Opinion on the diagnosis and treatment of human trichinellosis. Expert Opin Pharmacother. 2002;3:1117-1130.
14. Bielory L. Allergic and immunologic disorders of the eye. Part II: Ocular allergy. J Allergy Clin Immunol. 2000;106:1019-1032.
15. Owen DA, Poy E, Woodward DF, Daniel D. Evaluation of the role of Histamine H1- and H2-receptors in cutaneous inflammation in the guinea-pig produced by histamine and mast cell degranulation. Br J Pharmacol. 1980;69:615-623.
16. Abelson MB, Udell IJ. H2-receptors in the human ocular surface. Arch Ophthalmol. 1981;99:302-304.
17. Dachman WD, Bedarida G, Blaschke TF, Hoffman BB. Histamine-induced venodilation in human beings involves both H1 and H2 receptor subtypes. J Allergy Clin Immunol. 1994;93:606-614.
18. Abelson MB, Spangler D, Giovanoni A, Gomes P. Chemosis is an important diagnostic tool for evaluating new ophthalmic anti-allergic agents using the conjunctival allergen challenge model. Poster presented at: Annual Meeting of the American College of Allergy, Asthma and Immunology; November 12-17, 1999; Chicago, Ill.
19. Greiner JV, Peace DG, Baird RS, Allansmith MR. Effects of eye rubbing on the conjunctiva as a model of ocular inflammation. Am J Ophthalmol. 1985;100:45-50.
20. Abelson MB, Chambers WA, Smith LM. Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis. Arch Ophthalmol. 1990;108:84-88.
21. Abelson MB. Comparison of the conjunctival allergen challenge model with the environmental model of allergic conjunctivitis. Acta Ophthalmol Scand Suppl. 1999;228:38-42.
22. Hajeer MY, Ayoub AF, Millett DT, et al. Three-dimensional imaging in orthognathic surgery: The clinical application of a new method. Int J Adult Orthodon Orthognath Surg. 2002;17:318-330.
23. Ji Y, Zhang F, Schwartz J, et al. Assessment of facial tissue expansion with three-dimensional digitizer scanning. J Craniofac Surg. 2002;13:687-692.
24. Yamada T, Mori Y, Minami K, et al. Three-dimensional analysis of facial morphology in normal Japanese children as control data for cleft surgery. Cleft Palate Craniofac J. 2002;39:517-526.
25. Handels H, Ehrhardt J, Plotz W, Poppl SJ. Three-dimensional planning and simulation of hip operations and computer-assisted construction of endoprostheses in bone tumor surgery. Comput Aided Surg. 2001;6:65-76.
26. Source Prescription Audit. Yardley, Pa: Verispan; 1997-2002. Monthly report.
27. Patanol [package insert]. Fort Worth, Tex: Alcon Laboratories, Inc; 2003.
28. Yanni JM, Stephens DJ, Miller ST. The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent. J Ocul Pharmacol Ther. 1996;12:389-400.
29. Nichols LA, Abelson MB, Chapin M, et al. Mast-cell stabilizing effects of olopatadine following allergen challenge in humans. Poster presented at: Annual Meeting of the Association for Research in Vision and Ophthalmology; May 4-9, 2003; Fort Lauderdale, Fla.
30. Cook EB, Stahl JL, Barney NP, Graziano FM. Olopatadine inhibits TNFalpha release from human conjunctival mast cells. Ann Allergy Asthma Immunol. 2000;84:504-508.